The FDA elevated a recall of intraocular lenses currently being wrapped up by Bausch + Lomb, following increased reports of ...

The judge wants Paso Robles Councilmember Chris Bausch and the city to release withheld public records in a matter of weeks.

Q1 2025 Management View CEO Thomas Appio highlighted an 8th consecutive quarter of year-over-year revenue and adjusted EBITDA ...

Shares of Bausch + Lomb (NYSE:BLCO) fell on Wednesday after the Canadian eyecare company announced lower-than-expected ...

After enacting a “poison pill” defense to protect itself from unwanted potential buyers, Bausch Health has spotted a major ...

Bausch + Lomb, a leading global eye health company, announced a voluntary recall of its Envista Aspire, Envista Envy and certain Envistar intraocular lens injector systems, according to the Food ...

LAVAL, Quebec (AP) — LAVAL, Quebec (AP) — Bausch Health Companies Inc. (BHC) on Wednesday reported a loss of $58 million in its first quarter. On a per-share basis, the Laval, Quebec-based company ...

Bausch + Lomb logged a widened loss in the first fiscal quarter as costs dragged. The Canadian eye-health company on Wednesday posted a widened loss of $212 million, or 60 cents a share for the three ...

Bausch + Lomb addresses recent IOL recall, ensuring safety with enhanced protocols and returning enVista lenses to market ...

Bausch + Lomb Corporation ( NYSE: BLCO) Q1 2025 Earnings Conference Call April 30, 2025 8:00 AM ET George Gadkowski - Vice President, Investor Relations & Business Insights Brent Saunders - Chairman & ...

Bausch + Lomb, a leading global eye health company, announced a voluntary recall of its Envista Aspire, Envista Envy and certain Envistar intraocular lens injector systems, according to the Food ...